FDA approves Boostrix to prevent three diseases in older people

Share this article:
FDA approves Boostrix to prevent three diseases in older people
FDA approves Boostrix to prevent three diseases in older people

The Food and Drug Administration has approved the Boostrix vaccine for the treatment of  tetanus, diphtheria and pertussis (whooping cough) in people ages 65 and older. Boostrix is the first vaccine approved to prevent all three diseases in older people.

“Pertussis is a highly contagious disease and outbreaks have occurred among the elderly in nursing homes and hospitals,” said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research


Share this article:

More in Products

FDA approves weight management drug

The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formulation.

PDI introduces new swab

PDI introduces new swab

PDI has debuted the Prevantics® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless access sites prior to ...

Oregon Freeze Dry releases Easy Meal

Oregon Freeze Dry releases Easy Meal

A new brand from Oregon Freeze Dry is designed to help long-term care and other healthcare facilities prepare for a disaster.